Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikel

DOI

    Christoph Bock, Max Planck Institute for Informatics, Florian Halbritter, Austrian Academy of Sciences, Francisco J. Carmona, L'Hospitalet de Llobregat, Sascha Tierling, Saarland University, Paul Datlinger, Austrian Academy of Sciences, Yassen Assenov, German Cancer Research Center, Heidelberg, María Berdasco, L'Hospitalet de Llobregat, Anke K. Bergmann, University Hospital Schleswig-Holstein, Keith Booher, Zymo Research Corporation, Florence Busato, CEA-Institut de Génomique, Mihaela Campan, University of Southern California, Christina Dahl, Kræftens Bekæmpelse, Christina M. Dahmcke, Kræftens Bekæmpelse, Dinh Diep, University of California, San Diego, Agustín F. Fernández, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Clarissa Gerhauser, German Cancer Research Center, Heidelberg, Andrea Haake, Christian-Albrechts-Universität zu Kiel, Katharina Heilmann, German Cancer Research Center, Heidelberg, Thomas Holcomb, Oncology Biomarker Development,
  • Dianna Hussmann
  • Mitsuteru Ito, Cambridge University, Ruth Kläver, Qiagen GmbH, Martin Kreutz, Qiagen GmbH, Marta Kulis, Universitat Autònoma Barcelona, Virginia Lopez, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Shalima S. Nair, University of New South Wales (UNSW) Australia, Dirk S. Paul, UCL, Nongluk Plongthongkum, University of California, San Diego, Wenjia Qu, Garvan Institute of Medical Research, Ana C. Queirós, Universitat Autònoma Barcelona, Frank Reinicke, Qiagen GmbH, Guido Sauter, University Medical Center Hamburg-Eppendorf, Thorsten Schlomm, University Medical Center Hamburg-Eppendorf, Aaron Statham, Garvan Institute of Medical Research, Clare Stirzaker, University of New South Wales (UNSW) Australia, Ruslan Strogantsev, Cambridge University, Rocío G. Urdinguio, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Kimberly Walter, Oncology Biomarker Development, Dieter Weichenhan, German Cancer Research Center, Heidelberg, Daniel J. Weisenberger, University of Southern California, Stephan Beck, UCL, Susan J. Clark, University of New South Wales (UNSW) Australia, Manel Esteller, Theoretical and Computational Neuroscience Group, Center of Brain and Cognition, Universitat Pompeu Fabra, 08018 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain., Anne C. Ferguson-Smith, Cambridge University, Mario F. Fraga, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Per Guldberg, Kræftens Bekæmpelse,
  • Lise Lotte Hansen
  • Peter W. Laird, Van Andel Research Institute, José I. Martín-Subero, Universitat Autònoma Barcelona, Anders O H Nygren, Agena Bioscience, Ralf Peist, Qiagen GmbH, Christoph Plass, German Cancer Research Center, Heidelberg, David S. Shames, Oncology Biomarker Development, Reiner Siebert, University Hospital of Ulm, Xueguang Sun, Zymo Research Corporation, Jörg Tost, CEA-Institut de Génomique, Jörn Walter, Saarland University, Kun Zhang, University of California, San Diego
OriginalsprogEngelsk
TidsskriftNature Biotechnology
Vol/bind34
Tidsskriftsnummer7
Sider (fra-til)726-737
Antal sider12
ISSN1087-0156
DOI
StatusUdgivet - 1 jul. 2016

Se relationer på Aarhus Universitet Citationsformater

ID: 101658805